Objective evaluation of generic drug information

Yakugaku Zasshi

Volumn 124, Issue 6, 2004, Pages 341-347

  Iijima, Hisashi ^a,b   Kamei, Miwako ^a   Koshimizu, Toshimasa ^c   Shiragami, Makoto ^a  

^a NIHON UNIVERSITY   (Japan)

^b Chiba Pharmaceutical Association   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Drug evaluation; Drug information; Drug price; Generic drug; Necessity factor; Pharmaceutical industry

Indexed keywords

ALFACALCIDOL; ALLOPURINOL; AMBROXOL; ATENOLOL; CAMOSTAT MESILATE; CILOSTAZOL; CIMETIDINE; ENALAPRIL MALEATE; GENERIC DRUG; LOXOPROFEN; LYSOZYME CHLORIDE; OXATOMIDE; PROBUCOL; TRIMEBUTINE MALEATE; UBIDECARENONE;

ARTICLE; DRUG COST; DRUG INDUSTRY; DRUG INFORMATION; DRUG PACKAGING; DRUG SCREENING; HUMAN; INTERVIEW; MATHEMATICAL COMPUTING; SIDE EFFECT; COMMERCIAL PHENOMENA; ECONOMICS; JAPAN; PHARMACOKINETICS; STATISTICS;

COMMERCE; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUGS, GENERIC; JAPAN; THERAPEUTIC EQUIVALENCY;

EID: 4143144421     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.124.341     Document Type: Article

References (4)

1. Ministry of Health, Labour and Welfare, Notification No. 0317001, Mar. 17. 2003.
2. Iijima H., Koshimizu T., Jpn. J. Drug Informatics, 4, 21-26 (2002).
3. Iijima H., Kurosaki T., Kamei M., Koshimizu T., Shiragami M., Jpn. J. Drug Informatics, 5, 33-34 (2003).
4. Iijima H., Kurosaki T., Kamei M., Koshimizu T., Shiragami M., Yakugaku Zasshi, 123, 1039-1047 (2003).